{"id":2213,"date":"2019-11-14T14:47:29","date_gmt":"2019-11-14T13:47:29","guid":{"rendered":"https:\/\/icoprevencio.cat\/uc\/?p=2213\/"},"modified":"2021-10-09T15:53:40","modified_gmt":"2021-10-09T14:53:40","slug":"risc-acumulat-dun-resultat-fals-positiu-en-el-cribratge-de-cancer-colorectal-2000-2017","status":"publish","type":"post","link":"https:\/\/icoprevencio.cat\/uc\/risc-acumulat-dun-resultat-fals-positiu-en-el-cribratge-de-cancer-colorectal-2000-2017\/","title":{"rendered":"Risc acumulat d&#8217;un resultat fals positiu en el cribratge de c\u00e0ncer colorectal (2000 &#8211; 2017)"},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"alignleft is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/Imatge-Web-Not\u00edcia-cumulative-risk-2.png\" alt=\"\" class=\"wp-image-2236\" width=\"379\" height=\"372\" srcset=\"https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/Imatge-Web-Not\u00edcia-cumulative-risk-2.png 779w, https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/Imatge-Web-Not\u00edcia-cumulative-risk-2-300x295.png 300w, https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/Imatge-Web-Not\u00edcia-cumulative-risk-2-768x756.png 768w, https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/Imatge-Web-Not\u00edcia-cumulative-risk-2-750x738.png 750w, https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/Imatge-Web-Not\u00edcia-cumulative-risk-2-30x30.png 30w\" sizes=\"auto, (max-width: 379px) 100vw, 379px\" \/><\/figure><\/div>\n\n\n\n<p> L&#8217;objectiu d&#8217;aquest estudi ha estat estimar el risc acumulat d&#8217;un resultat fals positiu (FP d&#8217;ara en endavant) en el test de sang oculta en femta al llarg de 7 rondes de cribratge; i identificar els seus factors associats en un programa poblacional de cribratge de c\u00e0ncer colorectal. Durant el per\u00edode 2000 &#8211; 2017, el risc acumulat d&#8217;un resultat FP ha estat d\u2019un 16,2%, ajustant per edat, sexe i tipus de test. Els participants que van iniciar el cribratge a l&#8217;edat de 50 anys van presentar una probabilitat de tenir un FP en 4 rondes de cribratge de 7,3%, amb el test guayaco, i d\u2019un 12,4%, amb el test immunoqu\u00edmic. L&#8217;edat, el test immunoqu\u00edmic en femta, el primer cribratge i el nombre de cribratges personals s\u00f3n factors associats a un resultat FP.<br>El risc acumulat d&#8217;un FP en el cribratge colorectal utilitzant un test de sang oculta en femta sembla acceptable, ja que la colonosc\u00f2pia allarga el temps fins que es requereix un cribratge colorectal addicional, mentre que la taxa de complicacions es mant\u00e9 relativament baixa. <\/p>\n\n\n\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31488415\">http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31488415<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;objectiu d&#8217;aquest estudi ha estat estimar el risc acumulat d&#8217;un resultat fals positiu (FP d&#8217;ara en endavant) en el test de sang oculta en femta al llarg de 7 rondes de cribratge; i identificar els seus factors associats en un programa poblacional de cribratge de c\u00e0ncer colorectal. Durant el per\u00edode 2000 &#8211; 2017, el risc [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":2214,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_vp_format_video_url":"","_vp_image_focal_point":[],"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2213","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"uagb_featured_image_src":{"full":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",600,340,false],"thumbnail":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev-150x150.jpg",150,150,true],"medium":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev-300x170.jpg",300,170,true],"medium_large":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",600,340,false],"large":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",600,340,false],"1536x1536":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",600,340,false],"2048x2048":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",600,340,false],"vp_sm":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",500,283,false],"vp_md":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",600,340,false],"vp_lg":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",600,340,false],"vp_xl":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",600,340,false],"vp_sm_popup":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",500,283,false],"vp_md_popup":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",600,340,false],"vp_xl_popup":["https:\/\/icoprevencio.cat\/uc\/wp-content\/uploads\/sites\/2\/2019\/11\/cancer-epi-biomarket-prev.jpg",600,340,false]},"uagb_author_info":{"display_name":"xesco","author_link":"https:\/\/icoprevencio.cat\/uc\/author\/xesco\/"},"uagb_comment_info":0,"uagb_excerpt":"L&#8217;objectiu d&#8217;aquest estudi ha estat estimar el risc acumulat d&#8217;un resultat fals positiu (FP d&#8217;ara en endavant) en el test de sang oculta en femta al llarg de 7 rondes de cribratge; i identificar els seus factors associats en un programa poblacional de cribratge de c\u00e0ncer colorectal. Durant el per\u00edode 2000 &#8211; 2017, el risc&hellip;","_links":{"self":[{"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/posts\/2213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/comments?post=2213"}],"version-history":[{"count":3,"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/posts\/2213\/revisions"}],"predecessor-version":[{"id":4668,"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/posts\/2213\/revisions\/4668"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/media\/2214"}],"wp:attachment":[{"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/media?parent=2213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/categories?post=2213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/icoprevencio.cat\/uc\/wp-json\/wp\/v2\/tags?post=2213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}